Divis Laboratories Ltd (DIVISLAB) News & Corporate Actions | Announcements, Board Meetings, Splits, Bonuses, Rights Issues

{
  "main_header": {
    "sid": 509760,
    "name": "Divi's Lab.",
    "stock_name": "Divi's Lab.",
    "full_name": "Divis Laboratories Ltd",
    "name_url": "stocks-analysis/divi-s-lab",
    "exchange": 0,
    "exchangecode": "",
    "primexch": 1,
    "country_id": 34,
    "currency": "INR",
    "cmp": "6,706.10",
    "chg": 53.05,
    "chgp": "0.8%",
    "dir": 1,
    "prev_price": "6,653.05",
    "mcapval": "176,442.00 Cr",
    "mcap": "Large Cap",
    "scripcode": 532488,
    "symbol": "DIVISLAB",
    "ind_name": "Pharmaceuticals & Biotechnology",
    "ind_code": 4,
    "indexname": "India SENSEX",
    "isin": "INE361B01024",
    "curr_date": "May 06",
    "curr_time": "",
    "bse_nse_vol": "3.32 lacs",
    "exc_status": "Active",
    "traded_date": "May 06, 2026",
    "traded_date_str": "2026 05 06",
    "score": "",
    "scoreText": "",
    "Live": 0,
    "market_time": 0,
    "is_blur": 1,
    "is_blur_class": "blur-register-score-header",
    "is_blur_url": "https://www.marketsmojo.com/mojofeed/register?redirect=/stocks-analysis/divi-s-lab-509760-0&utm_source=Spage_Header_Score",
    "mojoone": {
      "ismore": 0,
      "all_data": []
    }
  },
  "news": {
    "results": [
      {
        "title": "Divis Laboratories Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-upgraded-to-hold-by-marketsmojo-on-technical-and-financial-improvements-3975166",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_mojoScore_3975166.png",
        "date": "2026-05-05 08:17:33",
        "description": "Divis Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook alongside steady financial performance. The upgrade, effective from 4 May 2026, is driven by a combination of enhanced technical indicators, stable quality metrics, valuation considerations, and positive financial trends, positioning the stock as a cautious but promising pick within the Pharmaceuticals & Biotechnology sector."
      },
      {
        "title": "Divis Laboratories Ltd Technical Momentum Shifts Signal Stabilisation Amid Mixed Indicators",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-ltd-technical-momentum-shifts-signal-stabilisation-amid-mixed-indicators-3974767",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_technicaldot_3974767.png",
        "date": "2026-05-05 08:03:01",
        "description": "Divis Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a stabilising outlook for the large-cap pharmaceutical player amid broader market fluctuations."
      },
      {
        "title": "Divis Laboratories Ltd is Rated Sell",
        "link": "https://www.marketsmojo.com/news/stock-recommendation/divis-laboratories-ltd-is-rated-sell-3972039",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/5/DivisLaboratori_mojoScore_3972039.png",
        "date": "2026-05-01 10:10:42",
        "description": "Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date perspective on its performance and outlook."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-bullish-market-positioning-3961148",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3961148.png",
        "date": "2026-04-24 15:00:30",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.58% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal dip in the stock price, the underlying volume and futures data suggest a complex interplay of bullish and cautious sentiment among traders."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3961020",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3961020.png",
        "date": "2026-04-24 14:00:19",
        "description": "Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.14% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price decline of 0.33% on 24 Apr 2026, the stock outperformed its sector by 1.49%, reflecting complex underlying dynamics in trading behaviour and sentiment."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3959458",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3959458.png",
        "date": "2026-04-23 15:00:24",
        "description": "Divis Laboratories Ltd, a large-cap pharmaceutical heavyweight, has witnessed a notable 13.7% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector on 23 Apr 2026, reflecting a complex interplay between bullish bets and cautious sentiment."
      },
      {
        "title": "Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-notable-surge-in-derivatives-open-interest-amid-mixed-market-signals-3957732",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3957732.png",
        "date": "2026-04-22 15:00:12",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.36% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite this increase, the stock’s performance remains largely in line with its sector peers, reflecting a nuanced market sentiment amid broader index weakness."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3957672",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3957672.png",
        "date": "2026-04-22 14:00:08",
        "description": "Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 14.6% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.05% price gain, the underlying dynamics suggest a complex interplay of directional bets and liquidity considerations amid a broadly cautious market environment."
      },
      {
        "title": "Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals",
        "link": "https://www.marketsmojo.com/news/stocks-in-action/divis-laboratories-sees-sharp-open-interest-surge-amid-mixed-market-signals-3957633",
        "imagepath": "https://i.marketsmojo.com/newsimg/2026/4/DivisLaboratori_oi_spurts_by_underlying_3957633.png",
        "date": "2026-04-22 13:00:07",
        "description": "Divis Laboratories Ltd has witnessed a notable 13.8% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price decline, the surge in open interest and volume patterns suggest evolving directional bets within the pharmaceuticals sector."
      }
    ],
    "total": 620,
    "sid": "509760",
    "stock_news_url": "https://www.marketsmojo.com/news/divis-laboratories-509760"
  },
  "announcements": [
    {
      "caption": "Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018",
      "datetime": "06-Apr-2026",
      "details": "Certificate pursuant to Regulation 74(5) of the SEBI (DP) Regulations 2018 for the quarter ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Closure of Trading Window",
      "datetime": "31-Mar-2026",
      "details": "Intimation of closure of Trading Window from April 01 2026 till 48 hours of declaration of audited financial results for the quarter and financial year ended March 31 2026.",
      "source": "BSE"
    },
    {
      "caption": "Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015",
      "datetime": "21-Mar-2026",
      "details": "Intimation about Draft Order issued under Section 144C(1) of the Income Tax Act 1961 for FY2022-23.",
      "source": "BSE"
    }
  ],
  "corporate_actions": [
    {
      "img": "board-meeting.svg",
      "title": "BOARD MEETING",
      "msg": "<span>No</span> Upcoming Board Meetings",
      "data": []
    },
    {
      "img": "dividend.svg",
      "title": "DIVIDEND",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has declared <strong>1500%</strong> dividend, ex-date: 25 Jul 25",
          "dt": "2025-07-25",
          "middle_text": "Dividend Alert"
        }
      ]
    },
    {
      "img": "splits.svg",
      "title": "SPLITS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>2:10</strong> stock split, ex-date: 03 Aug 07",
          "dt": "2007-08-03",
          "middle_text": "Split"
        }
      ]
    },
    {
      "img": "bonus.svg",
      "title": "BONUS",
      "msg": "",
      "data": [
        {
          "txt": "Divis Laboratories Ltd has announced <strong>1:1</strong> bonus issue, ex-date: 23 Sep 15",
          "dt": "2015-09-23",
          "middle_text": "Bonus Alert"
        }
      ]
    },
    {
      "img": "rights-issues.svg",
      "title": "RIGHTS",
      "msg": "No <strong>Rights</strong> history available",
      "data": []
    }
  ]
}

News and Views

Divis Laboratories Ltd Upgraded to Hold by MarketsMOJO on Technical and Financial Improvements

2026-05-05 08:17:33

Divis Laboratories Ltd has seen its investment rating upgraded from Sell to Hold, reflecting a notable improvement in its technical outlook alongside steady financial performance. The upgrade, effective from 4 May 2026, is driven by a combination of enhanced technical indicators, stable quality metrics, valuation considerations, and positive financial trends, positioning the stock as a cautious but promising pick within the Pharmaceuticals & Biotechnology sector.

Read full news article

Divis Laboratories Ltd Technical Momentum Shifts Signal Stabilisation Amid Mixed Indicators

2026-05-05 08:03:01

Divis Laboratories Ltd has exhibited a notable shift in its technical momentum, moving from a mildly bearish stance to a more neutral sideways trend. This change is underscored by mixed signals from key technical indicators such as MACD, RSI, and moving averages, suggesting a stabilising outlook for the large-cap pharmaceutical player amid broader market fluctuations.

Read full news article

Divis Laboratories Ltd is Rated Sell

2026-05-01 10:10:42

Divis Laboratories Ltd is rated 'Sell' by MarketsMOJO, with this rating last updated on 01 Feb 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 01 May 2026, providing investors with an up-to-date perspective on its performance and outlook.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Bullish Market Positioning

2026-04-24 15:00:30

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 12.58% surge in open interest in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite a marginal dip in the stock price, the underlying volume and futures data suggest a complex interplay of bullish and cautious sentiment among traders.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-24 14:00:19

Divis Laboratories Ltd, a leading player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.14% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price decline of 0.33% on 24 Apr 2026, the stock outperformed its sector by 1.49%, reflecting complex underlying dynamics in trading behaviour and sentiment.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-23 15:00:24

Divis Laboratories Ltd, a large-cap pharmaceutical heavyweight, has witnessed a notable 13.7% surge in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite this, the stock underperformed its sector on 23 Apr 2026, reflecting a complex interplay between bullish bets and cautious sentiment.

Read full news article

Divis Laboratories Sees Notable Surge in Derivatives Open Interest Amid Mixed Market Signals

2026-04-22 15:00:12

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 10.36% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and evolving investor positioning. Despite this increase, the stock’s performance remains largely in line with its sector peers, reflecting a nuanced market sentiment amid broader index weakness.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-22 14:00:08

Divis Laboratories Ltd, a prominent player in the Pharmaceuticals & Biotechnology sector, has witnessed a notable 14.6% surge in open interest (OI) in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a modest 0.05% price gain, the underlying dynamics suggest a complex interplay of directional bets and liquidity considerations amid a broadly cautious market environment.

Read full news article

Divis Laboratories Sees Sharp Open Interest Surge Amid Mixed Market Signals

2026-04-22 13:00:07

Divis Laboratories Ltd has witnessed a notable 13.8% increase in open interest in its derivatives segment, signalling heightened market activity and shifting investor positioning. Despite a marginal price decline, the surge in open interest and volume patterns suggest evolving directional bets within the pharmaceuticals sector.

Read full news article

View All News